Home » AKORN, INC. AND NATCO PHARMA LIMITED SIGN A DEFINITIVE API SUPPLY AND MARGIN SHARING AGREEMENT
AKORN, INC. AND NATCO PHARMA LIMITED SIGN A DEFINITIVE API SUPPLY AND MARGIN SHARING AGREEMENT
Akorn, Inc. today announced that it has signed an API Supply and Margin Sharing Agreement with Natco Pharma Limited, located in Hyderabad, India, to commercialize two ANDA injectable drug products.
Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=637167)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May